{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:52:55Z","timestamp":1792684375589,"version":"4.5.0"},"reference-count":35,"publisher":"Impact Journals, LLC","issue":"50","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,12,13]]},"DOI":"10.18632\/oncotarget.12696","type":"journal-article","created":{"date-parts":[[2016,10,15]],"date-time":"2016-10-15T14:25:31Z","timestamp":1476541531000},"page":"82493-82503","source":"Crossref","is-referenced-by-count":27,"title":["Anti-FIRs (PUF60) auto-antibodies are detected in the sera of early-stage colon cancer patients"],"prefix":"10.18632","volume":"7","author":[{"given":"Sohei","family":"Kobayashi","sequence":"first","affiliation":[{"name":"Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba City, Chiba 260-8670, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyuji","family":"Hoshino","sequence":"additional","affiliation":[{"name":"Department of Physical Chemistry, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaki","family":"Hiwasa","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Satoh","sequence":"additional","affiliation":[{"name":"Divisions of Clinical Mass Spectrometry and Clinical Genetics, Chiba University Hospital, Chiba 260-8670, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahityar","family":"Rahmutulla","sequence":"additional","affiliation":[{"name":"Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba City, Chiba 260-8670, Japan"},{"name":"Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba City, Chiba 260-8670, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachio","family":"Tsuchida","sequence":"additional","affiliation":[{"name":"Divisions of Clinical Mass Spectrometry and Clinical Genetics, Chiba University Hospital, Chiba 260-8670, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Komukai","sequence":"additional","affiliation":[{"name":"Department of Physical Chemistry, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba City, Chiba 260-8670, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisahiro","family":"Matsubara","sequence":"additional","affiliation":[{"name":"Department of Academic Surgery, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Toho University Omori Medical Center, Tokyo 143-8541, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Nomura","sequence":"additional","affiliation":[{"name":"Divisions of Clinical Mass Spectrometry and Clinical Genetics, Chiba University Hospital, Chiba 260-8670, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba City, Chiba 260-8670, Japan"},{"name":"Department of Laboratory Medicine & Division of Clinical Genetics and Proteomics Chiba University Hospital, Chiba 260-8670, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,10,15]]},"reference":[{"issue":"6","key":"1","first-page":"1145","article-title":"Puf60: A prominent new target of the autoimmune response in dermatomyositis and sjogren's syndrome","volume":"75","author":"Casciola-Rosen","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1158\/0008-5472.CAN-04-4459","article-title":"An essential role of alternative splicing of c-myc suppressor fuse-binding protein-interacting repressor in carcinogenesis","volume":"66","author":"Ochiai","year":"2006","journal-title":"Cancer Res"},{"key":"3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cas.12058","article-title":"Sap155-mediated c-myc suppressor far-upstream element-binding protein-interacting repressor splicing variants are activated in colon cancer tissues","volume":"104","author":"Nomura","year":"2013","journal-title":"Cancer Sci"},{"key":"4","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/hep.27218","article-title":"Overexpression of far upstream element (fuse) binding protein (fbp)-interacting repressor (fir) supports growth of hepatocellular carcinoma","volume":"60","author":"Weber","year":"2014","journal-title":"Hepatology"},{"key":"5","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.18632\/oncotarget.1650","article-title":"Alternative splicing of fbp-interacting repressor coordinates c-myc, p27kip1\/cycline and ku86\/xrcc5 expression as a molecular sensor for bleomycin-induced dna damage pathway","volume":"5","author":"Nomura","year":"2014","journal-title":"Oncotarget"},{"key":"6","doi-asserted-by":"publisher","first-page":"5102","DOI":"10.18632\/oncotarget.3244","article-title":"Haploinsufficiency of the c-myc transcriptional repressor fir, as a dominant negative-alternative splicing model, promoted p53-dependent t-cell acute lymphoblastic leukemia progression by activating notch1","volume":"6","author":"Kito","year":"2015","journal-title":"Oncotarget"},{"key":"7","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/path.4588","article-title":"Concomitant expression of far upstream element (fuse) binding protein (fbp) interacting repressor (fir) and its splice variants induce migration and invasion of non-small cell lung cancer (nsclc) cells","volume":"237","author":"Singer","year":"2015","journal-title":"J Pathol"},{"key":"8","doi-asserted-by":"crossref","first-page":"18538","DOI":"10.1016\/S0021-9258(17)44785-5","article-title":"A far upstream element stimulates c-myc expression in undifferentiated leukemia cells","volume":"265","author":"Levens","year":"1990","journal-title":"J Biol Chem"},{"key":"9","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/nrc2231","article-title":"Reflecting on 25 years with myc","volume":"8","author":"Penn","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1101\/gad.8.4.465","article-title":"A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new dna-binding motif","volume":"8","author":"Levens","year":"1994","journal-title":"Genes Dev"},{"key":"11","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1074\/jbc.270.14.8241","article-title":"Targeted melting and binding of a dna regulatory element by a transactivator of c-myc","volume":"270","author":"Avigan","year":"1995","journal-title":"J Biol Chem"},{"key":"12","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1128\/MCB.16.6.2656","article-title":"Multiple single-stranded cis elements are associated with activated chromatin of the human c-myc gene","volume":"16","author":"Levens","year":"1996","journal-title":"Mol Cell Biol"},{"key":"13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1097-2765(00)80428-1","article-title":"The fbp interacting repressor targets tfiih to inhibit activated transcription","volume":"5","author":"Levens","year":"2000","journal-title":"Mol Cell"},{"key":"14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(01)00223-9","article-title":"Defective interplay of activators and repressors with tfih in xeroderma pigmentosum","volume":"104","author":"Levens","year":"2001","journal-title":"Cell"},{"key":"15","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nsmb.2517","article-title":"Transcription-dependent dynamic supercoiling is a short-range genomic force","volume":"20","author":"Levens","year":"2013","journal-title":"Nat Struct Mol Biol"},{"key":"16","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cell.2013.04.033","article-title":"Global regulation of promoter melting in naive lymphocytes","volume":"153","author":"Vermeulen","year":"2013","journal-title":"Cell"},{"key":"17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1349-7006.2006.00137.x","article-title":"Strong HLA-DR antigen expression on cancer cells relates to better prognosis of colorectal cancer patients: Possible involvement of c-myc suppression by interferon-gamma","volume":"97","author":"Ochiai","year":"2006","journal-title":"Cancer Sci"},{"key":"18","first-page":"1777","article-title":"P53 antibodies in the sera of patients with various types of cancer: A review","volume":"60","author":"Soussi","year":"2000","journal-title":"Cancer Research"},{"key":"19","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1017\/S1355838299991938","article-title":"Puf60: A novel u2af65-related splicing activity","volume":"5","author":"Sharp","year":"1999","journal-title":"Rna"},{"key":"20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.onc.1205005","article-title":"Mgea6 is tumor-specific overexpressed and frequently recognized by patient-serum antibodies","volume":"21","author":"Meese","year":"2002","journal-title":"Oncogene"},{"key":"21","doi-asserted-by":"publisher","first-page":"16420","DOI":"10.18632\/oncotarget.7500","article-title":"Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting","volume":"7","author":"Brenner","year":"2016","journal-title":"Oncotarget"},{"key":"22","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/mt.2014.129","article-title":"Escrt-mediated uptake and degradation of brain-targeted alpha-synuclein single chain antibody attenuates neuronal degeneration","volume":"22","author":"Masliah","year":"2014","journal-title":"Mol Ther"},{"key":"23","doi-asserted-by":"crossref","first-page":"17305","DOI":"10.3748\/wjg.v20.i46.17305","article-title":"Alternative splicing of dna damage response genes and gastrointestinal cancers","volume":"20","author":"Nomura","year":"2014","journal-title":"World J Gastroenterol"},{"key":"24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jaad.2014.12.009","article-title":"Distinctive cutaneous, systemic features associated with antitranscriptional intermediary factor-1gamma antibodies in adults with dermatomyositis","volume":"72","author":"Casciola-Rosen","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"25","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1158\/0008-5472.CAN-14-3426","article-title":"TIF1gamma Suppresses Tumor Progression by Regulating Mitotic Checkpoints and Chromosomal Stability","volume":"75","author":"Ansieau","year":"2015","journal-title":"Cancer Res"},{"key":"26","doi-asserted-by":"crossref","first-page":"6156","DOI":"10.1038\/ncomms7156","article-title":"Tumour suppressor TRIM33 targets nuclear beta-catenin degradation","volume":"6","author":"Huang","year":"2015","journal-title":"Nat Commun"},{"key":"27","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.27273","article-title":"Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis, indicates poor prognosis of hepatocellular carcinoma","volume":"60","author":"Zhang","year":"2014","journal-title":"Hepatology"},{"key":"28","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0003-2697(82)90677-7","article-title":"A dot-immunobinding assay for monoclonal and other antibodies","volume":"119","author":"Gordon","year":"1982","journal-title":"Anal Biochem"},{"key":"29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/104063879700900109","article-title":"Serologic diagnosis of canine leishmaniasis by dot-elisa","volume":"9","author":"Portus","year":"1997","journal-title":"J Vet Diagn Invest"},{"key":"30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0022-1759(89)90321-9","article-title":"Quantitative dot-blot enzyme immunoassay for serum amyloid a protein","volume":"116","author":"Ogata","year":"1989","journal-title":"J Immunol Methods"},{"key":"31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1042\/bj2460019","article-title":"The use of monoclonal antibodies to distinguish several chemically modified forms of human alpha 1-proteinase inhibitor","volume":"246","author":"Chan","year":"1987","journal-title":"Biochem J"},{"key":"32","first-page":"60","article-title":"Elevated serum antibody levels against cyclin l2 in patients with esophageal squamous cell carcinoma","volume":"7","author":"Kuboshima","year":"2015","journal-title":"J Cancer Sci Ther"},{"key":"33","first-page":"1","article-title":"Identification of cerebral infarction-specific antibody markers from autoantibodies detected in patients with systemic lupus erythematosus","volume":"6","author":"Uzawa","year":"2015","journal-title":"Journal of Molecular Biomarkers & Diagnosis"},{"key":"34","first-page":"097","article-title":"Elevated levels of autoantibodies against atp2b4 and bmp-1 in sera of patients with atherosclerosis-related diseases","volume":"11","author":"Nishi","year":"2015","journal-title":"Immunome Res"},{"key":"35","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1148\/radiology.148.3.6878708","article-title":"A method of comparing the areas under receiver operating characteristic curves derived from the same cases","volume":"148","author":"McNeil","year":"1983","journal-title":"Radiology"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T12:36:14Z","timestamp":1657456574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,15]]},"references-count":35,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2016,12,13]]}},"alternative-id":["12696","27756887"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.12696","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,15]]}}}